Fact check: Did Newsom’s mental health court hit his goal for helping Californians? - CalMatters
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Gov. Gavin Newsom this week claimed a major victory for CARE Court, his program to provide mental health treatment to Californians with serious conditions. Did it really help 10,000 people?”
Gov. Gavin Newsom claimed a major victory for his signature mental health court on Thursday, but critics say his math appears more than a little fuzzy.
This article is an excerpt. To read the full content, visit the original source. CalMatters
Related articles
First Partner Siebel Newsom co-hosts summit elevating social connection as an urgent public health priority at the Vatican - California State Portal | CA.gov
What you need to know: First Partner Jennifer Siebel Newsom and Chancellor Marcelo Suárez-Orozco, in patronage of the Pontifical Academy of Social Sciences, convened global scientists, academicians, doctors, faith leaders, state officials, and advocates for a two-day summit exploring opportunities to advance social connection and belonging in a time of uncertainty and division. VATICAN CITY – First Partner Jennifer Siebel Newsom and Chancellor Marcelo Suárez-Orozco, in patronage of the Pontifical Academy of Social Sciences (PASS), co-hosted a two-day international summit at the historic Casina Pio IV at the Vatican last week. The summit brought together cross-sector leaders to confront the growing global crisis of social disconnection, advance a shared agenda to treat social health with the same urgency as physical and mental health, and share all of the programs that California and other communities across the world have modeled to answer this call.
Bioengineer.org | Switching HIV drugs or adding zoledronic acid rebuilds bone lost to tenofovir - European AIDS Treatment Group
Bioengineer.org news storyFor millions of people living with HIV, antiretroviral therapy has transformed a once-fatal infection into a manageable chronic condition. Yet the very drugs that suppress the virus can carry quiet costs, and one of the most insidious is bone loss. Tenofovir disoproxil fumarate, or TDF, has been a cornerstone of HIV treatment worldwide for two decades, prized for its potency, durability, and low cost. But a growing body of evidence has linked TDF exposure to measurable reductions in bone mineral density, raising an increasingly urgent clinical question: once bone has been lost on a TDF-based regimen, can it be recovered? A new prospective cohort study, published in BMC Infectious Diseases, offers some of the most detailed longitudinal evidence to date that the answer, for many patients, is yes. The research team enrolled 223 virologically suppressed men living with HIV who had low bone mineral density while taking TDF-based antiretroviral therapy.
0 comments
No comments yet. Be the first to share your thoughts!